Zidovudin (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Zidovudin" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

15nih.gov

4^th place

8^th place

12doi.org

2^nd place

5^th place

6wikipedia.org

low place

2karger.com

4,489^th place

722^nd place

2medicinenet.com

3,840^th place

598^th place

1web.archive.org

1^st place

2^nd place

1who.int

195^th place

64^th place

1nytimes.com

7^th place

37^th place

1harvard.edu

18^th place

31^st place

1archive.org

6^th place

9^th place

archive.org

Yarchoan R; Mitsuya H; Broder S (1988). »AIDS therapies«. Sci Am. 259 (4): 110–9. doi:10.1038/scientificamerican1088-110. PMID 3072667.

doi.org

Broder, S. (2009). »The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic«. Antiviral Research. 85 (1): 1–2. doi:10.1016/j.antiviral.2009.10.002. PMC 2815149. PMID 20018391. uredi
Horwitz, JP; Chua, J; Noel, MJ (1964). »The monomesylates of 1-(2-deoxy-bd-lyxofuranosyl) thymines«. Org. Chem. Ser. Monogr. 29: 2076–2079. doi:10.1021/jo01030a546.
Ostertag, W.; Roesler, G.; Krieg, C. J.; Kind, J.; Cole, T.; Crozier, T.; Gaedicke, G.; Steinheider, G.; Kluge, N.; Dube, S. (1974). »Induction of endogenous virus and of thymidine kinase by bromodeoxyuridine in cell cultures transformed by Friend virus«. Proceedings of the National Academy of Sciences of the United States of America. 71 (12): 4980–4985. Bibcode:1974PNAS...71.4980O. doi:10.1073/pnas.71.12.4980. PMC 434023. PMID 4531031. uredi
Mitsuya H; Weinhold K; Furman P; St Clair M; Lehrman S; Gallo R; Bolognesi D; Barry D; Broder S (1985). »3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro«. Proc Natl Acad Sci USA. 82 (20): 7096–7100. doi:10.1073/pnas.82.20.7096. PMC 391317. PMID 2413459.
Yarchoan R; Mitsuya H; Myers C; Broder S (1989). »Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides«. N Engl J Med. 321 (11): 726–38. doi:10.1056/NEJM198909143211106. PMID 2671731.
Yarchoan R; Klecker R; Weinhold K; Markham P; Lyerly H; Durack D; Gelmann E; Lehrman S; Blum R; Barry D (1986). »Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex«. Lancet. 1 (8481): 575–80. doi:10.1016/S0140-6736(86)92808-4. PMID 2869302.
Fischl MA; Richman DD; Grieco MH; Gottlieb MS; Volberding PA; Laskin OL; Leedom JM; Groopman JE; Mildvan D; Schooley RT; in sod. (1987). »The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial«. N Engl J Med. 317 (4): 185–191. doi:10.1056/NEJM198707233170401. PMID 3299089.
De Clercq E (1994). »HIV resistance to reverse transcriptase inhibitors«. Biochem Pharmacol. 47 (2): 155–69. doi:10.1016/0006-2952(94)90001-9. PMID 7508227.
Yarchoan R; Mitsuya H; Broder S (1988). »AIDS therapies«. Sci Am. 259 (4): 110–9. doi:10.1038/scientificamerican1088-110. PMID 3072667.
Scruggs, E. R.; Dirks Naylor, A. J. (2008). »Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy« (pdf). Pharmacology. 82 (2): 83–88. doi:10.1159/000134943. PMID 18504416. uredi
Scruggs, E. R.; Dirks Naylor, A. J. (2008). »Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy« (pdf). Pharmacology. 82 (2): 83–88. doi:10.1159/000134943. PMID 18504416. uredi
Fisher, J. W. (1997). »Erythropoietin: physiologic and pharmacologic aspects«. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine. 216 (3): 358–369. doi:10.3181/00379727-216-44183. PMID 9402140. uredi

harvard.edu

ui.adsabs.harvard.edu

Ostertag, W.; Roesler, G.; Krieg, C. J.; Kind, J.; Cole, T.; Crozier, T.; Gaedicke, G.; Steinheider, G.; Kluge, N.; Dube, S. (1974). »Induction of endogenous virus and of thymidine kinase by bromodeoxyuridine in cell cultures transformed by Friend virus«. Proceedings of the National Academy of Sciences of the United States of America. 71 (12): 4980–4985. Bibcode:1974PNAS...71.4980O. doi:10.1073/pnas.71.12.4980. PMC 434023. PMID 4531031. uredi

karger.com

content.karger.com

Scruggs, E. R.; Dirks Naylor, A. J. (2008). »Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy« (pdf). Pharmacology. 82 (2): 83–88. doi:10.1159/000134943. PMID 18504416. uredi
Scruggs, E. R.; Dirks Naylor, A. J. (2008). »Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy« (pdf). Pharmacology. 82 (2): 83–88. doi:10.1159/000134943. PMID 18504416. uredi

medicinenet.com

»ZIDOVUDINE (AZT) - ORAL (Retrovir) side effects, medical uses, and drug interactions«. MedicineNet. Pridobljeno 9. januarja 2006.
»zidovudine, Retrovir«. Medicinenet.com. 12. avgust 2010. Pridobljeno 14. decembra 2010.

nih.gov

pubmed.ncbi.nlm.nih.gov

Broder, S. (2009). »The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic«. Antiviral Research. 85 (1): 1–2. doi:10.1016/j.antiviral.2009.10.002. PMC 2815149. PMID 20018391. uredi
Ostertag, W.; Roesler, G.; Krieg, C. J.; Kind, J.; Cole, T.; Crozier, T.; Gaedicke, G.; Steinheider, G.; Kluge, N.; Dube, S. (1974). »Induction of endogenous virus and of thymidine kinase by bromodeoxyuridine in cell cultures transformed by Friend virus«. Proceedings of the National Academy of Sciences of the United States of America. 71 (12): 4980–4985. Bibcode:1974PNAS...71.4980O. doi:10.1073/pnas.71.12.4980. PMC 434023. PMID 4531031. uredi
Mitsuya H; Weinhold K; Furman P; St Clair M; Lehrman S; Gallo R; Bolognesi D; Barry D; Broder S (1985). »3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro«. Proc Natl Acad Sci USA. 82 (20): 7096–7100. doi:10.1073/pnas.82.20.7096. PMC 391317. PMID 2413459.
Yarchoan R; Mitsuya H; Myers C; Broder S (1989). »Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides«. N Engl J Med. 321 (11): 726–38. doi:10.1056/NEJM198909143211106. PMID 2671731.
Yarchoan R; Klecker R; Weinhold K; Markham P; Lyerly H; Durack D; Gelmann E; Lehrman S; Blum R; Barry D (1986). »Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex«. Lancet. 1 (8481): 575–80. doi:10.1016/S0140-6736(86)92808-4. PMID 2869302.
Fischl MA; Richman DD; Grieco MH; Gottlieb MS; Volberding PA; Laskin OL; Leedom JM; Groopman JE; Mildvan D; Schooley RT; in sod. (1987). »The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial«. N Engl J Med. 317 (4): 185–191. doi:10.1056/NEJM198707233170401. PMID 3299089.
De Clercq E (1994). »HIV resistance to reverse transcriptase inhibitors«. Biochem Pharmacol. 47 (2): 155–69. doi:10.1016/0006-2952(94)90001-9. PMID 7508227.
Yarchoan R; Mitsuya H; Broder S (1988). »AIDS therapies«. Sci Am. 259 (4): 110–9. doi:10.1038/scientificamerican1088-110. PMID 3072667.
Scruggs, E. R.; Dirks Naylor, A. J. (2008). »Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy« (pdf). Pharmacology. 82 (2): 83–88. doi:10.1159/000134943. PMID 18504416. uredi
Scruggs, E. R.; Dirks Naylor, A. J. (2008). »Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy« (pdf). Pharmacology. 82 (2): 83–88. doi:10.1159/000134943. PMID 18504416. uredi
Fisher, J. W. (1997). »Erythropoietin: physiologic and pharmacologic aspects«. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine. 216 (3): 358–369. doi:10.3181/00379727-216-44183. PMID 9402140. uredi
Fisher, J. W. (2003). »Erythropoietin: physiology and pharmacology update«. Experimental biology and medicine (Maywood, N.J.). 228 (1): 1–14. PMID 12524467. uredi

ncbi.nlm.nih.gov

Broder, S. (2009). »The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic«. Antiviral Research. 85 (1): 1–2. doi:10.1016/j.antiviral.2009.10.002. PMC 2815149. PMID 20018391. uredi
Ostertag, W.; Roesler, G.; Krieg, C. J.; Kind, J.; Cole, T.; Crozier, T.; Gaedicke, G.; Steinheider, G.; Kluge, N.; Dube, S. (1974). »Induction of endogenous virus and of thymidine kinase by bromodeoxyuridine in cell cultures transformed by Friend virus«. Proceedings of the National Academy of Sciences of the United States of America. 71 (12): 4980–4985. Bibcode:1974PNAS...71.4980O. doi:10.1073/pnas.71.12.4980. PMC 434023. PMID 4531031. uredi
Mitsuya H; Weinhold K; Furman P; St Clair M; Lehrman S; Gallo R; Bolognesi D; Barry D; Broder S (1985). »3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro«. Proc Natl Acad Sci USA. 82 (20): 7096–7100. doi:10.1073/pnas.82.20.7096. PMC 391317. PMID 2413459.

nytimes.com

query.nytimes.com

»A Failure Led to Drug Against AIDS«. The New York Times. 20. september 1986. Pridobljeno 30. junija 2010.

web.archive.org

»WHO Model List of Essential Medicines« (PDF). World Health Organization. Marec 2005. Arhivirano iz prvotnega spletišča (PDF) dne 12. februarja 2007. Pridobljeno 12. marca 2006.

who.int

whqlibdoc.who.int

»WHO Model List of Essential Medicines« (PDF). World Health Organization. Marec 2005. Arhivirano iz prvotnega spletišča (PDF) dne 12. februarja 2007. Pridobljeno 12. marca 2006.

wikipedia.org

sl.wikipedia.org

Broder, S. (2009). »The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic«. Antiviral Research. 85 (1): 1–2. doi:10.1016/j.antiviral.2009.10.002. PMC 2815149. PMID 20018391. uredi
Ostertag, W.; Roesler, G.; Krieg, C. J.; Kind, J.; Cole, T.; Crozier, T.; Gaedicke, G.; Steinheider, G.; Kluge, N.; Dube, S. (1974). »Induction of endogenous virus and of thymidine kinase by bromodeoxyuridine in cell cultures transformed by Friend virus«. Proceedings of the National Academy of Sciences of the United States of America. 71 (12): 4980–4985. Bibcode:1974PNAS...71.4980O. doi:10.1073/pnas.71.12.4980. PMC 434023. PMID 4531031. uredi
Scruggs, E. R.; Dirks Naylor, A. J. (2008). »Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy« (pdf). Pharmacology. 82 (2): 83–88. doi:10.1159/000134943. PMID 18504416. uredi
Scruggs, E. R.; Dirks Naylor, A. J. (2008). »Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy« (pdf). Pharmacology. 82 (2): 83–88. doi:10.1159/000134943. PMID 18504416. uredi
Fisher, J. W. (1997). »Erythropoietin: physiologic and pharmacologic aspects«. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine. 216 (3): 358–369. doi:10.3181/00379727-216-44183. PMID 9402140. uredi
Fisher, J. W. (2003). »Erythropoietin: physiology and pharmacology update«. Experimental biology and medicine (Maywood, N.J.). 228 (1): 1–14. PMID 12524467. uredi